PHIA Koninklijke Philips N.V.

Philips introduces next-generation enterprise imaging solution to connect every step of the patient journey at RSNA 2019

Philips introduces next-generation enterprise imaging solution to connect every step of the patient journey at RSNA 2019



December 1, 2019

Scalable, flexible solution embeds intelligence and analytics across clinical and operational workflows

Chicago, U.S. and Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced its next-generation enterprise imaging solution. The introduction follows several years of strategic investments in R&D and complementary acquisitions, resulting in a suite of integrated products that deliver a comprehensive platform designed to connect clinical capabilities and optimize workflows around every step in the patient’s journey. The new solution is being unveiled at the .

“Our new solution seamlessly embeds intelligence at every step of each operational workflow and disease pathway, providing the foundation for advanced enterprise imaging today and the fully integrated precision diagnosis platform of tomorrow,” said Calum Cunningham, General Manager Enterprise Diagnostic Informatics at Philips. “The solution will enable patients, clinicians and hospital administrators to fully harness the power of information and translate it into actionable insights – a critical next step to advance the healthcare enterprise.”

At RSNA 2019, Philips is highlighting its patient-centered approach to a precision diagnosis and treatment selection. By demonstrating advanced clinical and operational capabilities, embedded with AI and analytics, Philips simplifies and enhances workflows across the entire enterprise imaging network, including image acquisition, viewing and data interpretation, and diagnostic patient management workflows.

Further demonstrating the company’s focus on patient-centered care, Philips is investing in industry-wide standardization and interoperability programs. The company recently became one of the first major health technology companies to be certified to provide strategic assessment and guidance using the HIMSS Analytics . It has also adopted , which seeks to advance platforms for technology interoperability.

The new enterprise imaging solution supports hospitals and imaging centers as they seek to connect and optimize performance, improving the patient experience, health outcomes, and staff experience, while lowering the cost of care. It includes:

An integrated offering that provides support throughout the patient journey: Even before they reach the hospital, Philips’ diagnostic patient management application orchestrates and streamlines patient interactions with their health system before and after procedures, maximizing engagement while helping to improve operational efficiency. Workflow management automates scheduling flexibility, tracks patient results efficiently and enables the most urgent studies to be automatically delivered together with advanced reporting to the most qualified radiologists.

Image sharing and interoperability to support shared decision making: In any healthcare environment, seamless, securely managed access to data and efficient workflow is critical. The solution includes a vendor-neutral, zero-footprint enterprise viewer and a secure web portal to provide patient access to relevant clinical information. In addition, Philips Forcare Interoperability allows systems, departments and stakeholders to communicate with each other and exchange data, seamlessly linking information from different sources.

Comprehensive diagnostic solutions and advanced visualization: The solution provides comprehensive solutions for radiology, cardiology, neurology, pathology, oncology, and breast imaging, alongside comprehensive advanced visualization and quantification software and interactive multimedia reporting including EMR, RIS and PACS integration.

Operational insights to improve productivity: Philips’ Enterprise Operational Informatics offering is built to support structural optimization of the operational performance of imaging departments. The suite includes a broad range of applications, both user-focused and cloud-based, providing insights into operations and performance across vendor neutral modalities. In addition, it includes clinical analytics to enable a more proactive care model, providing business-critical information and a secure remote connection.

Clinical repository for archiving and storage: The solution’s clinical repository includes a vendor neutral archive, smart lifecycle management to provide storage and access beyond individual episodes of care, and an acquisition portal to capture images across departments, modalities and file formats.

Integrated AI applications across the imaging workflow: The solution’s IntelliSpace AI Workflow Suite [1] enables healthcare providers to seamlessly integrate AI applications into the imaging workflow. The comprehensive solution provides a full suite of applications for integration and centralized workflow management of AI algorithms, delivering structured results wherever they’re needed across the healthcare enterprise.

The next-generation enterprise imaging solution will be commercially available in Q1 2020.

Philips is demonstrating its imaging solutions at the 2019 Radiological Society of North America (RSNA) Annual Meeting in booth #6730. In addition to the main booth, Philips will also be highlighting its AI capabilities at an additional booth as part of the AI showcase (booth #10109). For more Philips news from RSNA click and follow for #RSNA19 live updates.

[1] IntelliSpace AI Workflow Suite is not intended for diagnosis or treatment selection. Work in progress, not available for sale.

For further information, please contact:

Mark Groves

Philips Global Press Office

Tel.:

Email:

Twitter:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

 

Attachments

EN
01/12/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation ...

Philips agrees to acquire SpectraWAVE Inc., advancing next-generation coronary intravascular imaging and physiological assessment with AI December 15, 2025 Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary arteries, and X1TM-FFR, an AI-enabled angio-based FFR technology that delivers rapid, accurate coronary physiology assessment from a single angiogram [1] SpectraWAVE’s technologies have the potential to significantly increase adoption of corona...

 PRESS RELEASE

Philips reiterates timing of 2026 outlook

Philips reiterates timing of 2026 outlook December 4, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today reaffirmed that its 2026 outlook will be issued as planned on February 10, in line with the company’s previously communicated schedule. As previously guided, the company expects continued performance improvement with sequential comparable sales growth, expanded margins (despite tariff headwinds) and strong cashflow. The company continues to expect comparative sales growth to accelerate sequentially in 2026 towards mid-single-digit gro...

 PRESS RELEASE

Philips expands commercial availability of world’s first real-time AI-...

Philips expands commercial availability of world’s first real-time AI-enabled light-based 3D navigation solution for image-guided therapy December 1, 2025 Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA – (NYSE: PHG, AEX: PH...

 PRESS RELEASE

Philips launches Verida, world’s first detector-based spectral CT powe...

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision November 30, 2025 Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA – At RSNA 2025, (NYSE: PHG, AEX: PHIA), a global leader in health techno...

 PRESS RELEASE

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MR...

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform November 30, 2025 Major technology breakthrough combines advanced AI for clinical insights and accelerated workflow in new premium 3.0T MRI platform [1] Amsterdam, the Netherlands, and Chicago, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled BlueSeal Horizon [1], an entirely new 3.0T MRI innovation platform that includes the industry’s first helium-free 3.0T magnet at . A pivotal advance in MRI innovation, helium-free [2] 3.0T is a major scientific achievement set to have s...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch